22-28773013-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_173510.4(CCDC117):c.164C>T(p.Ala55Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000427 in 1,172,214 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173510.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC117 | NM_173510.4 | c.164C>T | p.Ala55Val | missense_variant | 1/5 | ENST00000249064.9 | NP_775781.1 | |
CCDC117 | NM_001284263.2 | c.164C>T | p.Ala55Val | missense_variant | 1/4 | NP_001271192.1 | ||
CCDC117 | NM_001284264.2 | c.164C>T | p.Ala55Val | missense_variant | 1/4 | NP_001271193.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC117 | ENST00000249064.9 | c.164C>T | p.Ala55Val | missense_variant | 1/5 | 1 | NM_173510.4 | ENSP00000249064.4 |
Frequencies
GnomAD3 genomes AF: 0.0000134 AC: 2AN: 149626Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000293 AC: 3AN: 1022588Hom.: 0 Cov.: 31 AF XY: 0.00000416 AC XY: 2AN XY: 481310
GnomAD4 genome AF: 0.0000134 AC: 2AN: 149626Hom.: 0 Cov.: 33 AF XY: 0.0000274 AC XY: 2AN XY: 73012
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 08, 2024 | The c.164C>T (p.A55V) alteration is located in exon 1 (coding exon 1) of the CCDC117 gene. This alteration results from a C to T substitution at nucleotide position 164, causing the alanine (A) at amino acid position 55 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at